Fairmount Funds Management LLC sold COGT
January 22, 2026 · Form 4 insider transaction
Fairmount Funds Management LLC sold 3,500,000 shares of Cogent Biosciences, Inc. at $36.40 per share, a transaction worth $127.40M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,500,000
Price
$36.40
Total value
$127.40M
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 22, 2026
Filing dateJanuary 22, 2026
Shares owned after5,503,418
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the securities held by Fairmount Healthcare Fund II LP ("Fund II"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.